Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.16
-0.07 (-0.85%)
At close: Nov 13, 2026, 4:00 PM EST
8.16
0.00 (0.00%)
After-hours: Nov 13, 2026, 7:45 PM EST
Prothena Corporation Revenue
Prothena Corporation had revenue of $620.00K in the quarter ending September 30, 2026, a decrease of -74.33%. This brings the company's total for the last twelve months to $52.74M, up 347.44% year-over-year. In the year 2025, Prothena Corporation had annual revenue of $9.68M, down -92.83%. That makes Prothena Corporation the 27,622nd largest company in the world by revenue and 3,743rd in the United States.
Revenue (ttm)
$52.74M
Revenue Growth
+347.44%
P/S Ratio
7.95
Revenue / Employee
$787,090
Employees
67
Market Cap
419.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.68M | -125.47M | -92.83% |
| Dec 31, 2024 | 135.16M | 43.79M | 47.92% |
| Dec 31, 2023 | 91.37M | 37.47M | 69.50% |
| Dec 31, 2022 | 53.91M | -146.67M | -73.13% |
| Dec 31, 2021 | 200.58M | 199.72M | 23,414.30% |
| Dec 31, 2020 | 853.00K | 39.00K | 4.79% |
| Dec 31, 2019 | 814.00K | -141.00K | -14.76% |
| Dec 31, 2018 | 955.00K | -26.56M | -96.53% |
| Dec 31, 2017 | 27.52M | 26.46M | 2,508.44% |
| Dec 31, 2016 | 1.06M | -552.00K | -34.35% |
| Dec 31, 2015 | 1.61M | -49.25M | -96.84% |
| Dec 31, 2014 | 50.85M | 50.18M | 7,422.78% |
| Dec 31, 2013 | 676.00K | -1.98M | -74.57% |
| Dec 31, 2012 | 2.66M | 2.15M | 424.26% |
| Dec 31, 2011 | 507.00K | -736.00K | -59.21% |
| Dec 31, 2010 | 1.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Arvinas | 275.30M |
| Puma Biotechnology | 231.83M |
| ARS Pharmaceuticals | 122.14M |
| Assembly Biosciences | 67.01M |
| Fennec Pharmaceuticals | 66.37M |
| CytomX Therapeutics | 14.03M |
| SL Science Holding | 3.27M |
| Avalo Therapeutics | 59.00K |
PRTA News
- 9 days ago - Prothena Reports Third Quarter 2026 Financial Results and Business Highlights - Business Wire
- 9 days ago - Prothena Corporation Earnings release: Q3 2026 - Filings
- 9 days ago - Prothena Corporation Quarterly report: Q3 2026 - Filings
- 16 days ago - Prothena to Report Third Quarter 2026 Financial Results on November 5 - Business Wire
- 17 days ago - Prothena Corporation Slides: Corporate presentation - Filings
- 2 months ago - Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 3 months ago - Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - Business Wire
- 3 months ago - Prothena Corporation Earnings release: Q2 2026 - Filings